Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C

BACKGROUND: Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Davitkov, Perica, Chandar, Apoorva Krishna, Hirsch, Amy, Compan, Anita, Silveira, Marina G., Anthony, Donald D., Smith, Suzanne, Gideon, Clare, Bonomo, Robert A., Falck-Ytter, Yngve
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065164/
https://ncbi.nlm.nih.gov/pubmed/27741230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0163945
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia